Real Estate Stocks Offer Nice Income. Bank CDs Look Even Better.
Letters to the editors of Barron’s about REITs, the federal deficit, weight-loss drugs, recession risks, Rockwell Automation, and more.
Source: marketwatch.com
📰 Dave Ricks News
Page 8 - Dave Ricks News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Dave Ricks. Real-time updates on events, politics, business and more.
Eli Lilly Stock Is Riding the Wave of Anti-Obesity Drugs. Its Dominance Could Last for Years.
Lilly has a drug in testing that sets a new standard for weight loss, and another behind it that could improve on that. The challenge for the company:...
Source: marketwatch.com
Eli Lilly CEO Dave Ricks Has Lead the Way in Obesity, Alzheimer's Treatments
In 10 years, the CEO predicts doctors will view obesity the same way they do high blood pressure today.
United States Jack Hough Eli Lilly Dave Ricks Lilly Genetic Medicines Institute Genetic Medicines Institute
Source: marketwatch.com
Eli Lilly Leads the Way in Obesity, Alzheimer's Treatments Under Dave Ricks
Job No. 1 for Eli Lilly CEO Dave Ricks is to ramp up production of the company’s diabetes drug tirzepatide ahead of its expected approval for obesity later…
Source: biztoc.com
CEOs matter when picking stocks. Here are 5 things we look for
Our goal is to invest in businesses that make money over the long run. That's why we care so much about who is charge.
Source: cnbc.com
A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen | Local News
Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and
Source: noozhawk.com
Pre-admission program to show students a path to college
During the recently concluded session of the Indiana General Assembly, lawmakers passed new reading initiatives, added limits to high-school graduation waivers, and increased post-secondary education support.
Source: journalgazette.net
A more aggressive FTC is starting to target drug mergers and industry middlemen
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by President Donald Trump.
Source: usf.edu
A More Aggressive FTC Is Starting to Target Drug Mergers and Industry Middlemen
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
Source: kffhealthnews.org
A more aggressive FTC is starting to target drug mergers and industry middlemen
Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is moving against drug companies and industry middlemen as part of the Biden administration's push for lower drug prices at the pharmacy counter.
Source: news-medical.net